| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 04/08/1999 | WO1998055154A9 Radioprotectant for peptides labeled with radioisotope |
| 04/08/1999 | CA2304458A1 Contrasting agent for infarct and necrosis imaging |
| 04/07/1999 | EP0906762A1 Diagnostic agent for angiopathic diseases |
| 04/07/1999 | EP0906129A1 Implantable medical device |
| 04/07/1999 | EP0906015A1 Liver retention clearing agents |
| 04/07/1999 | EP0854716A4 Androgenic directed compositions |
| 04/07/1999 | EP0810855A4 Polyalkylene block copolymers as surface modifiers for nanoparticles |
| 04/07/1999 | EP0569531B1 Stabilized antibody fragments |
| 04/07/1999 | CN1213316A Polymeric delivery of radionuclides and radiopharmaceuticals |
| 04/07/1999 | CN1042794C Improved emulsions of highly fluorinated organic compounds |
| 04/06/1999 | US5891704 Method to produce high levels of methioninase |
| 04/06/1999 | US5891418 Use as a diagnostic imaging, radiotherapeutic, or therapeutic agent |
| 04/06/1999 | CA2107567C Detection of cardiovascular lesions |
| 04/01/1999 | WO1999015665A2 Mutants of thyroid stimulating hormone and methods based thereon |
| 04/01/1999 | WO1999015653A2 Tie ligand homologues |
| 04/01/1999 | WO1999015205A1 Immunization against streptococcus pneumoniae using conjugated and unconjugated pneumococcal polysaccharide vaccines |
| 04/01/1999 | WO1999002545A3 Antigen binding fragments, designated 4b5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 04/01/1999 | WO1999000150A3 Drug targeting of a peptide radiopharmaceutical through the primate blood-brain barrier in vivo with a monoclonal antibody to the human insulin receptor |
| 04/01/1999 | WO1998057665A3 The use of mononuclear phagocytes in in vivo imaging of hypoxic/ischaemic tissue |
| 04/01/1999 | WO1998055153A9 Non-steroidal radiolabeled agonist/antagonist compounds and their use in prostate cancer imaging |
| 04/01/1999 | WO1998043678B1 Tetraaza- or n2s2- complexants, and their use in radiodiagnostics or radiotherapy |
| 04/01/1999 | WO1998024482A3 Use of endothelin conjugates in therapy, new endothelin conjugates, substances containing them, and processes for producing them |
| 04/01/1999 | DE19724229C1 Radioactive stents used in the production of implant for restenosis prophylaxis |
| 04/01/1999 | CA2304244A1 Immunization against streptococcus pneumoniae using conjugated and unconjugated pneumococcal polysaccharide vaccines |
| 04/01/1999 | CA2304129A1 Tie ligand homologues |
| 04/01/1999 | CA2302993A1 Mutants of thyroid stimulating hormone and methods based thereon |
| 04/01/1999 | CA2217382A1 Radiolabelling characteristics of novel iminophosphorane ligands with technetium-99m |
| 03/31/1999 | EP0905135A2 Cocaine receptor binding ligands |
| 03/31/1999 | EP0743861A4 Radiolabeled annexins |
| 03/31/1999 | EP0643705B1 PROCESS FOR PRODUCING N-beta-g(b)-HYDROXYALKYL-TRI-N-CARBOXYALKYL-1,4,7,10-TETRAAZACYCLODODECANE AND N-beta-g(b)-HYDROXYALKYL-TRI-N-CARBOXYALKYL-1,4,8,11-TETRAAZACYCLOTETRADECANE DERIVATIVES AND THEIR METAL COMPLEXES |
| 03/31/1999 | EP0567514B1 A system for enhanced in-vivo clearance of diagnostic and/or therapeutic agents by extracorporeal depletion of agents |
| 03/30/1999 | US5889146 Method for synthesis of bifunctional chelating agents-peptides |
| 03/30/1999 | US5888997 Radiation sensitization using texaphyrins |
| 03/30/1999 | US5888970 Technetium-99m labeled chelator incorporated cyclic peptides that bind to the GPIIb/IIIa receptor as imaging agents |
| 03/30/1999 | US5888812 Myeloid cell leukemia associated gene MCL-1 |
| 03/30/1999 | US5888508 Monoclonal antibodies against leukocyte adhesion receptor β-chain methods of producing these antibodies and use therefore |
| 03/30/1999 | US5888506 A detergent free polypeptide in the form of crystal structure or lyophilized or conjugated with polyoxyethylene glycol and contains less than 1 ng endotoxin per mg protein |
| 03/30/1999 | US5888475 Labeled cocaine analogs |
| 03/30/1999 | US5888474 Technetium-99m labeled peptides for GPIIb/IIIa ligands useful for thrombus imaging |
| 03/30/1999 | US5888473 Tumor therapy; boron cage compounds |
| 03/30/1999 | CA2039218C Boronic acid adducts of metal dioxime complexes useful in labelling proteins and other amine-containing compounds |
| 03/25/1999 | WO1999013920A2 Method for treating proliferative diseases by therapy |
| 03/25/1999 | WO1999000654A3 Radiolabeled farnesyl-protein transferase inhibitors |
| 03/25/1999 | DE19742880A1 Treatment of proliferative or atherosclerotic diseases |
| 03/25/1999 | CA2301887A1 Method for treating proliferative diseases by therapy |
| 03/24/1999 | EP0902687A1 Polymeric delivery of radionuclides and radiopharmaceuticals |
| 03/24/1999 | EP0810878B1 Rna photocleavage using texaphyrins |
| 03/24/1999 | EP0716647B1 Hydrazino-type n2s2 chelators |
| 03/24/1999 | EP0705346B1 Monoclonal antibodies against the alpha pdgf receptor and uses thereof |
| 03/23/1999 | US5886190 Reacting glycerol-1,3-ditosylate-2-o-acetylate with 2-nitroimidazole to form chemical intermediate 1-(2'-nitro-1'-imidazolyl)-2-o-acetyl-3-o-tosylpropanol in presence of dimethylformamide and cesium carbonate |
| 03/23/1999 | US5886143 Reagent including at least nine hexose residues connected in iteratively branched configuration, functional moiety capable of reacting with binding moiety, target moiety or active agent |
| 03/23/1999 | US5886142 Radiolabeled thrombus imaging agents |
| 03/23/1999 | US5885548 Diethylenetriaminepentaacetic acid derivatives, their complexes and complex salts, that contain an element of atomic numbers 20-32, 39-51 for use as contrast media and antidotes |
| 03/23/1999 | US5885547 Particulate material |
| 03/23/1999 | CA2051439C Liposomal targeting of ischemic tissue |
| 03/23/1999 | CA1340456C Chimeric rodent/human immunoglobulins specific for tumor-associated antigens |
| 03/18/1999 | WO1999013329A1 Methods of identifying molecules that home to angiogenic vasculature in tumors |
| 03/18/1999 | WO1999012579A1 Imaging agents for early detection and monitoring of cardiovascular plaque |
| 03/18/1999 | WO1999012533A1 A method of modulating cellular activity |
| 03/18/1999 | WO1998008481A3 Process and apparatus for the production of bi-212 and a use thereof |
| 03/18/1999 | CA2302837A1 Imaging agents for early detection and monitoring of cardiovascular plaque |
| 03/17/1999 | EP0901491A1 Tropane derivatives useable in particular for in vivo detection of dopamine transporters |
| 03/17/1999 | CN1210741A Method for preparing radiopharmaceutical kit for bone tumour curing or diagnosis |
| 03/16/1999 | US5882645 Peptide compounds |
| 03/16/1999 | US5882626 Therapy for killing tumor cells using antibodies |
| 03/16/1999 | US5882330 Drugs and methods for treating diseases |
| 03/11/1999 | WO1999011604A1 Sterilized 5-aminolevulinic acid |
| 03/11/1999 | WO1999011590A1 Fluorination of proteins and peptides for f-18 positron emission tomography |
| 03/11/1999 | WO1999011295A1 Imaging methods and compositions |
| 03/11/1999 | WO1999011294A1 Stable radioiodine conjugates and methods for their synthesis |
| 03/10/1999 | EP0505357B1 Method for antibody targeting of diagnostic or therapeutic agents |
| 03/09/1999 | US5879661 Imaging agents and methods for the preparation and use thereof |
| 03/09/1999 | US5879660 Radiolabeled glucans which bind to leukocytes, sites of infection, inflammation, atherosclerosis, or cancer |
| 03/09/1999 | US5879659 Images for diagnosis of cardiovascular disorders |
| 03/09/1999 | US5879658 Technetium-99m labeled peptides for thrombus imaging |
| 03/09/1999 | US5879657 Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders |
| 03/09/1999 | US5879656 Radioactive therapeutic agent, receptor binding moiety |
| 03/04/1999 | WO1999010016A1 Combinatorial library |
| 03/04/1999 | WO1998043678A3 Tetraaza- or n2s2- complexants, and their use in radiodiagnostics or radiotherapy |
| 03/04/1999 | CA2341969A1 Combinatorial library |
| 03/03/1999 | EP0898970A1 Diagnostic agent for digestive diseases |
| 03/03/1999 | EP0898478A1 Stimulation of host defence mechanisms against tumors |
| 03/03/1999 | EP0500928B1 Endocurietherapy |
| 03/02/1999 | US5877305 DNA encoding biosynthetic binding protein for cancer marker |
| 03/02/1999 | US5877289 Tissue factor compositions and ligands for the specific coagulation of vasculature |
| 03/02/1999 | US5877165 Boronated porhyrins and methods for their use |
| 03/02/1999 | US5876711 Binding of p53 to the second polynucleotide sequence causes the expression of the reporter molecule which can be detected or quantified. |
| 03/02/1999 | US5876708 Allogeneic and xenogeneic transplantation |
| 03/02/1999 | US5876698 Contrast agent for magnetic resonance imaging |
| 03/02/1999 | US5876695 Nuclear magnetic resonance contrast agent |
| 03/02/1999 | US5876694 Azavesamicols |
| 03/02/1999 | US5876693 Hydroxyalkyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals |
| 03/02/1999 | US5876691 Screening a bacteriophage library; diagnosis of colorectal tumors |
| 02/25/1999 | WO1999009047A1 Detection and treatment of breast, gynecological and prostate cancer |
| 02/25/1999 | WO1999008709A1 Stable radioactive medecine |
| 02/25/1999 | CA2297727A1 Detection and treatment of breast, gynecological and prostate cancer |
| 02/24/1999 | EP0897922A2 Cocaine receptor binding ligands |
| 02/24/1999 | CN1208656A 99M Tc-N,N'-diamineethyl propylenediamino hexaacetic acid developer and use therefor |
| 02/24/1999 | CN1208612A Sustained release and implantation type methotrexate medicine and method for preparing same |
| 02/24/1999 | CN1208610A Sustained release and implantation type mitomycin medicine and method for preparing same |